系统性硬化症的性别差异:从致病源到临床表现和治疗
Melpomeni Toitou1, Maria Iacovantuono2,3, Gesa Sauer2
1Department of Rheumatology, University Hospital of Zurich, University of Zurich, Rämistrasse 100, Zurich 8091, Switzerland.
系统性硬化症 (SSc) 影响女性更频繁,但男性经历更严重的疾病. 生物学和社会文化因素有助于SSc.这些与性别有关的差异.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
背景情况:
- 系统性硬化症 (SSc) 在患病率,临床表现和患者结果方面存在明显的性别差异.
- 虽然女性的诊断频率更高,但男性往往表现出更具侵略性的疾病过程,其特点是扩散性皮肤干扰,间歇性肺部疾病和生存率下降.
研究的目的:
- 审查目前对系统性硬化症 (SSc) 性差异的理解.
- 探索生物因素 (性激素,遗传) 和社会文化因素 (性别) 对 SSc. 的影响.
- 突出临床管理的影响,并确定未来的研究方向.
主要方法:
- 文献综述综合现有关于系统性硬化症性别相关差异的研究.
- 分析生物机制,包括荷尔蒙和遗传影响.
- 考虑社会文化因素及其对SSc的潜在影响.
主要成果:
- 生物因素,如性激素 (雌激素,雄激素) 和遗传元素 (X染色体失活) 显著影响SSc的性别偏见.
- 更年期和其他生命阶段调节疾病表达.
- 性别作为社会文化构造可能会影响疾病的感知和获得医疗保健,这需要进一步研究.
结论:
- 在SSc中与性别相关的差异是多因素的,涉及生物学和潜在的性别之间的复杂相互作用.
- 目前的临床建议缺乏性别特异性考虑,凸显了个性化治疗的差距.
- 进一步的研究至关重要,以阐明这些差异,并制定定制的SSc管理策略.
更多相关视频
05:44Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
Published on: October 13, 2023
09:08Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
Published on: October 14, 2021
相关概念视频
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
